tailieunhanh - UBS Balanced Investment Fund: Product Disclosure Statement

The $200 million AUM fund described earlier could therefore base its annual revenue projections around its $3 million management fee (., of AUM) and set its expense caps accordingly. Dur- ing a strong-performing year the fund will run with a surplus which, like other businesses, it can use for capital expenditures, incentive bonuses, cash reserves and so forth. A start-up fund can apply the same principal based on realistic AUM assumptions. (For most funds, “re- alistic” start-up capital consists of investments by partners, friends and family.) A fund with $20 million in start-up capital and a and 20 arrangement could. | UBS 18 June 2012 UBS Balanced Investment Fund Product Disclosure Statement Issue Issued by UBS Global Asset Management Australia Ltd ABN 31 003 146 290 AFSL No. 222605 ARSN 090 430 210 APIR SBC0815AU Contents 1. About UBS Global Asset Management Australia Ltd 2 2. How UBS Balanced Investment Fund works 2 3. Benefits of investing in UBS Balanced Investment Fund 3 4. Risks of managed investment schemes 3 5. How we invest your money 5 6. Fees and costs 6 7. How managed investment schemes are taxed 7 8. How to apply 8 9. Other information 8 This Product Disclosure Statement PDS is a summary of significant information and contains a number of references to important information in the UBS Additional Information Booklet which forms part of the PDS . You should consider both the information in this document and the information referred to in the UBS Additional Information Booklet before making a decision about investing in the UBS Balanced Investment Fund Fund . The information provided in this PDS is general information only and does not take account of your personal financial situation or needs. You should obtain financial advice tailored to your personal circumstances. UBS Global Asset Management Australia Ltd is the issuer of this PDS. No other member of the UBS group makes any statement or representation in this document. An investment in this Fund is not a deposit with or other liability of UBS AG or of any UBS Group company in Australia or elsewhere and is subject to investment risk including possible delays in repayment and loss of income or principal invested. Neither UBS AG the responsible entity nor any other UBS Group company guarantees the performance of the Fund the repayment of capital from the Fund or any particular rate of return. Some terms used in this PDS have special meanings. They are generally defined in this PDS. Other capitalised terms may be defined in the UBS Additional Information Booklet. 1. About UBS Global Asset Management Australia .

• Quỹ đầu tư
• Surface Compounds
• Cuticular Waxes
• Terpenoids
• Major Volatile
• Compounds Analysis
• Mezcal Fermentation
• Tạp chí khoa học
• Bioactive compounds
• Extraction temperature
• Extraction time
• Pouzolzia zeylanica plant
• Response surface methodology